Candela GentleMax
Dual-wavelength platform · 755nm alex + 1064nm Nd:YAG
Technology: Nd:YAG Laser
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New-unit reference · older model
- Not published
- Used asking price
- $25,900–$33,500Reported source: Used listing · Aug 30, 2026
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Latest price source dated: Aug 30, 2026
Read FDA-cleared indicationsExact wording from 3 FDA records
K063074 (Candela Corp., 2006)
755nm The Candela 3630 Laser System is indicated fir the temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. OCtall skin types (Fitzpatrick I-IV) including tamned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. 1064nm The Candela 3630 Laser System is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. The lasers are indicted on all skin types Fitzpatrick I-VI including tarmed skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemoangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe an lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of r'±d pigmentation in hypertrophic and keloid soars where vascularity is an integral part of the: soar. Treatment of wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K112715 (Candela Corp., 2011)
GentleMAX Family of Laser Systems Division of Surgical, Orthopedic, and Restorative Devices 755nm 5l0(k)Number, K 11i-iis The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable longterm or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick [-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias) 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PEB. The lasers are indicated on all skin types Fitzpatrick I-yE including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but 'not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K133283 (Candela Corp., 2013)
The GentleMAX Family of Laser Systems is indicated for the following: 'lS5nm The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick I- VI) including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas. telangiectasias. GentleMAX Family of Laser Systems 7-1 A3 - I 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of P113. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick 1-VI including tanned skin. Photocoagulation and hemlostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangiorna, warts. telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au lait macules, seborrheic keratosis, nevi. chloasma. verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hyperirophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Description: The Candela GentleMAX Family of Laser Systems contains two separate laser heads (Alexandrite and Nd:YAG), wvhich produce laser light Outputs of 755 rn and 1064 rn, respectively.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: August 30, 2026 · How we verify
No new-unit price reference is published for this older model.
Axis runs $0–$33,500. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Candela |
|---|---|
| Company | Owner: Apax Partners (funds advised by Apax) (private equity owned, since 2017) · Distribution: direct |
| Parent company | Candela Medical |
| Brand owner | Candela |
| Built by (OEM) | Candela Corporation |
| Category | Dual-wavelength platform |
| Technology | 755nm alex + 1064nm Nd:YAG |
| FDA status | FDA Cleared |
| 510(k) citation | K063074, K112715, K133283 |
| New-unit reference (older model) | Not published |
| Used asking range | $25,900–$33,500 |
| Consumables | Not published |
| Launch year | 2007 |
| Latest price source dated | Aug 30, 2026 |
| Manufacturer-source documents checked | Not published |
Overview
First combined alex/YAG Gentle platform
FDA & regulatory detailClearance timeline, authorization route and citation notes
FDA-cleared indications (verbatim)
K063074 (Candela Corp., 2006)
755nm The Candela 3630 Laser System is indicated fir the temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. OCtall skin types (Fitzpatrick I-IV) including tamned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. 1064nm The Candela 3630 Laser System is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. The lasers are indicted on all skin types Fitzpatrick I-VI including tarmed skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemoangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe an lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of r'±d pigmentation in hypertrophic and keloid soars where vascularity is an integral part of the: soar. Treatment of wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K112715 (Candela Corp., 2011)
GentleMAX Family of Laser Systems Division of Surgical, Orthopedic, and Restorative Devices 755nm 5l0(k)Number, K 11i-iis The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable longterm or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick [-VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas, telangiectasias) 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PEB. The lasers are indicated on all skin types Fitzpatrick I-yE including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but 'not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K133283 (Candela Corp., 2013)
The GentleMAX Family of Laser Systems is indicated for the following: 'lS5nm The GentleMAX Family of Laser Systems is indicated for temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing after a treatment regime. On all skin types (Fitzpatrick I- VI) including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as port-wine stains, hemangiomas. telangiectasias. GentleMAX Family of Laser Systems 7-1 A3 - I 1064nm The GentleMAX Family of Laser Systems is indicated for the removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of P113. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick 1-VI including tanned skin. Photocoagulation and hemlostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangiorna, warts. telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au lait macules, seborrheic keratosis, nevi. chloasma. verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The laser is also indicated for the reduction of red pigmentation in hyperirophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. Description: The Candela GentleMAX Family of Laser Systems contains two separate laser heads (Alexandrite and Nd:YAG), wvhich produce laser light Outputs of 755 rn and 1064 rn, respectively.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Nd:YAG — 755nm alex + 1064nm Nd:YAG
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Candela Medical
Legal manufacturer: Candela Corporation (United States)
Applicant on the FDA record
Candela Corp.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
- Vendor restrictions: no published lock — no electronic gating documented
Source notes
Dealer parts catalogs incl. DHX Laser, 30 Aug 2026 research pass.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Candela GentleMax data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published used asking range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History2 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 30, 2026
Used price range
18000-35000 → 25900-33500
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Candela GentleMax — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.
Browse current modelsDevice and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.